Treatment strategy and long-term outcome in patients with deep lumbosacral arteriovenous fistulas. A single center analysis in nineteen patients.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
01 2020
Historique:
received: 24 09 2019
revised: 06 11 2019
accepted: 10 11 2019
pubmed: 19 11 2019
medline: 29 4 2021
entrez: 19 11 2019
Statut: ppublish

Résumé

Deep lumbosacral dural arteriovenous fistulas (lsDAVF) are rare and present serious diagnostic and treatment difficulties. In our current analysis we present our treatment strategy and the long-term clinical outcome of nineteen patients with lsDAVF. We retrospectively analyzed our radiological and medical records for patients presenting with SDAVF between 1990 and 2018 at the University Hospital Aachen. We identified twenty patients with a lsDAVF. All patients were treated surgically. One patient died of pulmonary embolism three months after treatment and was excluded from our outcome analysis. Clinical data at time of admission, discharge, one year after discharge and at the last follow-up were evaluated according to modified Aminoff-Logue disability score (AL-score) for this analysis. Mean age was 65 ± 7 years (median, 67; range, 53-78), sixteen patients (84 %) were male. After surgery, four patients developed a recurrent fistula in the same shunt zone and were re-treated microsurgically. Follow-up data one year after treatment was available in 15 patients. No relevant changes in AL-score were observed within this period. For the long-term follow-up analysis, data of 13 patients were available; 38.5 % of patients developed late functional deterioration. In our cohort, patients with deep lumbosacral dural arteriovenous fistula had a higher risk of early recurrence compared to patients with thoracolumbar SDAVF, with a considerable percentage of late functional deterioration. Thus strict clinical and radiologic long-term follow-up examinations are recommended in those patients.

Identifiants

pubmed: 31739154
pii: S0303-8467(19)30392-0
doi: 10.1016/j.clineuro.2019.105596
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105596

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

F Jablawi (F)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany; Department of Neurosurgery, Justus-Liebig-University, Klinikstr. 33, 35396 Giessen, Germany. Electronic address: fidaa.jablawi@neuro.med.uni-giessen.de.

O Nikoubashman (O)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany.

M Dafotakis (M)

Department of Neurology, University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany.

G A Schubert (GA)

Department of Neurosurgery, University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany.

F-J Hans (FJ)

Department of Neurosurgery, Paracelsus Kliniken, Am Natruper Holz 69, 49076 Osnabrück, Germany.

M Mull (M)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Aachen, Pauwelsstr. 30, 52074 Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH